Data / Form D filings / Ceapro Inc.
Ceapro Inc.: Form D filing
Ceapro Inc., a biotechnology company in Edmonton, Alberta, Canada, filed a Form D with the SEC in 2016. The latest, on July 27, 2016, reports $7.7 million sold of a $7.7 million offering to 1 investor.
Find out what Ceapro Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 7824-51 AVENUE, Edmonton, Alberta, Canada, T6E 6
- Phone
- (780) 421-4555
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Alberta, Canada
- Revenue range
- $5,000,001 - $25,000,000
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1680765
The full lists. Form D filings in Biotechnology: 1,568 rows, $78.40, or the new rows each week for $19 a month. Form D filings: 44,302 rows, $523.02, or the new rows each week for $92.05 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Jul 27, 2016 | New notice | $7,713,074 | $7,713,074 | $0 | 1 | Jul 13, 2016 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Ulrich Kosciessa | Director | |
| Stacy Prefontaine | Executive Officer | |
| Gilles Gagnon | Executive Officer, Director | |
| Glenn Rourke | Director | |
| Donald Oborowsky | Director | |
| John Zupancic | Director | |
| William Li | Director |
Every Form D from the week of Jul 25, 2016 · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Ceapro Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.